Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retinopathy of Prematurity > Can virtual screening for retinopathy of prematurity work in rural areas?
  • Retinopathy of Prematurity

Can virtual screening for retinopathy of prematurity work in rural areas?

Ophthalmology 360

In rural and areas with limited resources, images with a noncontact fundus camera can be used to help detect treatable retinopathy of prematurity (ROP), according to a study.

Screening criteria included gestational age <36 weeks and/or birth weight (BW) <2000 g, or GA <36 weeks but BW ≥2000 g, with qualifying medical history. Retinal images we obtained by 2 technicians and graded by ophthalmologists experienced in ROP. The screening was stopped when retinal vessels in anterior zone II were normal on 2 successive evaluations or at 45 weeks postmenstrual.

Overall, 418 babies, with a mean GA of 33.9 ± 2.2 weeks (range, 27-36, and mean BW of 1728.3 ± 379.3 g (range, 840-2830 g), were screened. Signs of pre-plus or plus disease were noted in 8.6% of patients, of which 58% underwent an ophthalmologic examination.

Type 1 ROP was confirmed in 15 patients and 14 patients underwent training. Treated infants had a mean GA of 33.6 ± 3.0 weeks (range, 32-34.9) and a mean BW of 1,646 ± 245.8 g (range, 1100-1774.1 g).

Reference
Asturias AL, Gilbert C, Silva Jc JC, et al. Implementation of telemedicine screening for retinopathy of prematurity in rural areas in Guatemala. J AAPOS. 2021;S1091-8531(21)00649-2. doi: 10.1016/j.jaapos.2021.08.307. Epub ahead of print. PMID: 34973448.

Share

Related Content

  • Retina Care 360

Cost analysis shows greater losses for pediatric versus adult retinal detachment repairs

  • Glaucoma

PreserFlo MicroShunt shows short-term benefit in refractory childhood glaucoma

  • Pediatrics

Virtual reality vision therapy shows modest improvement in children with intermittent exotropia

  • Practice Management

New review highlights urgent need to tackle adherence gaps in eye care throughout the patient life cycle

  • Myopia

Dietary patterns linked to myopia risk in children and adolescents

  • Pediatrics

Did you know this rare condition has ocular implications?

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon